New oral anticoagulants in severe trauma patients: Enemy at the gates?

被引:5
|
作者
Egea-Guerrero, J. J. [1 ,2 ]
Quintana Diaz, M. [3 ,4 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Neurocrit, Unidad Gest Clin Cuidados Crit & Urgencias, Seville, Spain
[2] Univ Seville, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[3] Hosp Univ La Paz, IdiPAZ, Dept Urgencias, Madrid, Spain
[4] Hosp Univ La Paz, IdiPAZ, Unidad Cuidados Intens, Madrid, Spain
关键词
New oral anticoagulants; Trauma; Bleeding; Reversion; Prothrombin complex Concentrate; DABIGATRAN ETEXILATE; ATRIAL-FIBRILLATION; WARFARIN; REVERSAL; MANAGEMENT; METAANALYSIS; RIVAROXABAN; ANTIDOTE; SAFETY;
D O I
10.1016/j.medin.2014.09.008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The high incidence of trauma, especially in elderly people anticoagulated with new oral anticoagulants (NOAs), has become a major challenge, particularly in critical situations with Life-threatening bleeding. Under these circumstances, urgent NOA reversion becomes mandatory. Prothrombin complex has become a frequent indication in critical situations in which rapid reversal of anticoagulation is needed and where the use of fresh frozen plasma is limited. This study offers our point of view regarding the usefulness of NOAs, not only in the prevention of cardioembolic events but also as regards their emergent reversion in cases of severe bleeding associated to trauma. (C) 2014 Elsevier Espana, S.L.U. and SEMICYUC. All rights reserved.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 50 条
  • [21] Hemorrhagic stroke and new oral anticoagulants
    Derlon, V.
    Corbonnois, G.
    Martin, M.
    Toussaint-Hacquard, M.
    Audibert, G.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 (9-10): : 540 - 547
  • [22] Pharmacology and Safety of New Oral Anticoagulants The Challenge of Bleeding Persists
    Levy, Jerrold H.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (03) : 443 - +
  • [23] Severe Hemorrhage Associated With Oral Anticoagulants
    Lindhoff-Last, Edelgard
    Herrmann, Eva
    Lindau, Simone
    Konstantinides, Stavros
    Grottke, Oliver
    Nowak-Goettl, Ulrike
    Lucks, Jessica
    Zydek, Barbara
    von Heymann, Christian
    Birschmann, Ingvild
    Suemnig, Ariane
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Meybohm, Patrick
    Greinacher, Andreas
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (18): : 312 - +
  • [24] New oral anticoagulants in patients with chronic kidney disease
    Belmar Vega, Lara
    de Francisco, A. L. M.
    Bada da Silva, Jairo
    Galvan Espinoza, Luis
    Fernandez Fresnedo, Gema
    NEFROLOGIA, 2017, 37 (03): : 244 - 252
  • [25] New Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
    Deedwania, Prakash C.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (04) : 289 - 296
  • [26] Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
    Gomez-Outes, Antonio
    Alcubilla, Pau
    Calvo-Rojas, Gonzalo
    Terleira-Fernandez, Ana Isabel
    Suarez-Gea, Luisa
    Lecumberri, Ramon
    Vargas-Castrillon, Emilio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (24) : 2987 - 3001
  • [27] The AAST prospective observational multicenter study of the initial experience with reversal of direct oral anticoagulants in trauma patients
    Emigh, Brent
    Kobayashi, Leslie
    Kopp, Miroslav
    Daley, Mitch
    Teal, Lindsey
    Haan, James
    Burlew, Clay Cothren
    Nirula, Raminder
    Moore, Forrest
    Burruss, Sigrid
    Kaminski, Stephen
    Dunn, Julie
    Carrick, Matthew
    Schroeppel, Thomas
    Thurston, Brian
    Quick, Jacob
    Bosarge, Patrick
    Brown, Carlos, V
    AMERICAN JOURNAL OF SURGERY, 2021, 222 (02) : 264 - 269
  • [28] New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation
    Ando, Giuseppe
    Trio, Olimpia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 244 - 246
  • [29] Direct Oral Anticoagulants New Drugs and New Concepts
    Levy, Jerrold H.
    Spyropoulos, Alex C.
    Samama, Charles M.
    Douketis, James
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (12) : 1333 - 1351
  • [30] Bleeding in patients on anticoagulant therapy: the real utility of antidotes and how to manage bleeding in patients on new-generation oral anticoagulants
    Sanchez, Miquel
    Escolar, Gines
    Reverter, Joan Carles
    EMERGENCIAS, 2013, 25 (06): : 482 - 490